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DITORIAL
rotective  effects  of human  milk  antimicrobial
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oreast-feeding  provides  the  nursing  infant  with  a  plethora
f molecules  evolved  to  optimally  develop  the  infant’s
issues and  organs.  Human  milk  contains  numerous  bioac-
ive molecules  that  modulate  the  immune  system  as
ell as  molecules  with  direct  and  indirect  antimicrobial
ctivities that  avoid  overgrowth  of  potentially  pathogenic
icroorganisms. The  combination  of  immunmodulatory  and
ntimicrobial factors  help  the  child  to  avoid  the  devel-
pment of  inﬂammatory  diseases  and  childhood  infection.
ccordingly, the  feeding  of  formula  and  other  substitutes
o infants  is  clearly  correlated  with  an  increased  frequency
f inﬂammatory  diseases  such  as  allergies,  colitis,  juvenile
iabetes, and  childhood  cancer,  as  well  as  an  increased  fre-
uency of  infections.  Although  some  of  the  mechanisms  and
olecules involved  in  human  milk’s  protection  against  infec-
ion have  been  well  studied,  the  complete  picture  of  the
ery complex  biology  of  the  human  milk  anti-microbial  pro-
ection is  not  yet  clear.
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021-7557/© 2014 Sociedade Brasileira de Pediatria. Published by ElseviIn  a  study  published  in  this  issue  of  Jornal  de  Pediatria,1
 group  from  Instituto  Venezolano  de  Investigaciones  Cien-
íﬁcas (IVIC),  Caracas,  Venezuela,  led  by  Dr.  Luz  Thomas,
resents evidence  for  the  potential  role  of  human  beta-
efensin-2 (hBD-2)  from  human  milk  in  anti-microbial
rotection against  enteric  infections  and  potentially  other
nfections as  well.  The  authors  measured  the  concentra-
ion of  hBD-2  in  100  human  milk  samples,  61  of  which
ere from  colostrum  and  the  remaining  from  mature  milk.
imilar to  what  has  been  observed  in  one  earlier  study,2
olostrum  samples  contained  signiﬁcantly  higher  concen-
rations of  hBD-2  than  mature  milk  samples;  however,  the
oncentrations observed  here  were  considerably  higher  than
he previously  described,  suggesting  a  possible  contribu-
ion of  milk-derived  defensins  to  the  antimicrobial  defense
f milk  in  vivo.  The  authors  then  produced  recombinant
BD-2 and  tested  it  against  a  broad  range  of  poten-
ially pathogenic  enteric  organisms,  including  Salmonella
pp. and  Escherichia  coli  strains,  as  well  as  strains  of
erratia marcescens,  Pseudomonas  aeruginosa,  and  Acine-
obacter baumanii,  and  observed  a  sensitivity  of  these
rganisms to  hBD-2;  the  concentrations  found  in  human  milk
re likely  to  have  an  effect  on  these  organisms  in  vivo.
he results  represent  the  ﬁrst  report  of  defensin-levels
n milk  from  Latin  American  women  and  suggest  a  role
or hBD-2  in  the  defense  against  enteric  infections  in
nfants. This  information  will  hopefully  spur  on  future  stud-
es on  milk  antimicrobial  peptides  (AMPs)  from  this  and
er Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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other  groups,  increasing  the  understanding  of  the  role  of
AMPs in  both  immune  modulation  and  antimicrobial  activ-
ity.
To put  this  work  in  perspective,  there  is  strong
epidemiologic  data  suggesting  a  detrimental  association
between formula-feeding  and  infection  in  infants.3--5 When
comparing formula-fed  and  breast-fed  infants,  breast-
fed infants  present  lower  incidences  of  gastrointestinal,
respiratory, urinary  tract,  and  other  infections,  as  well
as lower  child  mortality.6 The  main  molecules  associ-
ated with  this  protection  are  antimicrobial  factors  in
human milk  that  act  either  indirectly  to  block  adher-
ence of  bacteria  to  mucosal  surfaces  or  to  neutralize
bacteria, such  as  oligosaccharides,  glycoconjugates,  and
immunoglobulins, or  directly  killing  microbes,  such  as
lactoferrin, lysozyme,  peroxidases,  fatty  acids,  and  other
molecules.7 Protection  is  further  ameliorated  by  provid-
ing factors  that  modulate  the  immune  system,5,8,9 such  as
cytokines and  growth  factors.  Additionally,  recent  studies
have shown  that  human  milk  contains  its  own  micro-
biome that,  when  provided  to  the  infant,  help  establish
a healthy  microﬂora  in  the  infant  gut  and  other  tissues,
which also  helps  to  optimally  develop  the  infant  immune
system and  to  protect  against  overgrowth  of  pathogenic
bacteria.10,11
The  role  of  milk  as  a  source  of  AMPs  and  the  role  of  milk
AMPs in  the  protection  against  infection  has  not  been  inves-
tigated in  depth.  Initial  studies  investigating  the  expression
of defensins  in  mammary  epithelium  found  expression  of
hBD-1, but  no  expression  of  hBD-2  was  observed.12 In  fact,
the major  beta-defensin  produced  in  milk  appears  to  be
hBD-1.2,13 Yet,  Armogida  et  al.  identiﬁed  expression  of  the
hbd-2 gene  in  15%  of  the  mammary  epithelial  cells  they
investigated,14 and  Wang  et  al.  was  recently  the  ﬁrst  group
to show  secretion  of  hBD-2  in  milk.2
AMPs  are  multifunctional  defense  molecules.15 Besides
their anti-microbial  activity,  they  also  modulate  the  immune
system by  activating  immune  cells  against  pathogenic  orga-
nisms. Their  importance  in  the  defense  against  infections
of mucosal  linings  such  as  the  skin,  respiratory  tract,  and
gut, has  been  clearly  demonstrated  using  animal  models,
where the  genes  for  mouse  defensins  or  cathelicidin  have
been removed  or  their  expression  has  been  reduced.  Such
studies have  shown  the  importance  of  AMPs  against  various
infections including  those  caused  by  E.  coli  O157:H7,  Strep-
tococcus pyogenes,  and  Streptococcus  pneumoniae,16--18 and
defensins and  defensin-like  molecules  are  known  to  con-
tribute to  bacterial  clearance  in  the  gut  and  lung.19 To
conclude, the  information  provided  by  Baricelli  et  al.1 in
the current  issue  of  this  journal  should  stimulate  future
studies in  the  ﬁeld  for  several  reasons.  Firstly,  further
studies will  increase  our  understanding  of  the  complex  biol-
ogy of  human  milk  and  its  anti-microbial  role  in  the  gut
and other  mucosal  tissues;  secondly,  the  study  of  APMs,
including defensins,  are  becoming  more  and  more  inter-
esting as  potential  antibiotics  in  the  era  of  antibiotic
resistance.20Conﬂicts of interest
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